• TransCelerate Launches “One Person Closer” Campaign To Inspire Clinical Trial Participation

    Clinical Informatics News | Looking to inspire healthcare professionals to believe in the positive value of clinical research for their patients, TransCelerate has launched “One Person Closer,” a campaign using social media and video vignettes to put a human face on clinical trials.

    Feb 23, 2018
  • Building A Community-Focused Clinical Trial Network For Alzheimer's Disease

    Clinical Informatics News | Dementia-related disorder trials, especially Alzheimer’s, are harder to recruit for and complete due to dementia’s unique characteristics and psychological effects on patients. The Global Alzheimer’s Platform Foundation is looking to analyze and address the difficulty of completing Alzheimer’s disease trials timely and cost-efficiently.

    Feb 22, 2018
  • News And Product Launches At SCOPE 2018

    Clinical Informatics News | Several companies took advantage of the 9th annual Summit for Clinical Ops Executives to make new product and business announcements. Here are a few of the exciting things heard and seen on the show floor.

    Feb 21, 2018
  • Peanut Allergy Therapy Scores Late-stage Trial Win

    STAT |  Based on the positive results, Aimmune Therapeutics expects to seek U.S. approval for its preventative peanut allergy therapy by the end of the year, with a European filing in 2019, the company said.

    Feb 20, 2018
  • Digital Engagement & The Future Of Clinical Trials

    Clinical Informatics News | Speakers at the 9th annual Summit for Clinical Ops Executives emphasized the importance of the clinical trials industry improving digital engagement with their patients. The warning: the patient isn’t waiting anymore.

    Feb 16, 2018
  • Clinical Informatics News Announces Best Practices Awards Winners

    Clinical Informatics News | The winners of the Clinical Informatics News Best Practices Awards were announced on Wednesday at the Summit for Clinical Ops Executives, SCOPE, in Orlando, Fla. Prizes were awarded to CRF Health, IQVIA, and Bioclinica.

    Feb 14, 2018
  • Fox Insight’s Observational Clinical Study Offers Hope For Parkinson’s Disease Cures

    Clinical Informatics News | The Michael J. Fox Foundation for Parkinson’s Research is using patient reported outcomes to find a cure for Parkinson’s Disease with Fox Insight, a “patient-powered”, observational online clinical study.

    Feb 12, 2018
  • Patient Advocate Says Novartis $475,000 Breakthrough Should Cost Just $160,000

    Forbes |  David Mitchell, 67, says he's sure that Novartis' Kymriah is a breakthrough medicine, and that he will need a similar medicine to treat his own blood cancer. He's sure of something else, too: Novartis is charging too much.

    Feb 8, 2018